Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-14 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
M | Common Stock | A | 20834 | $0.00 - $0.00 | $0 |
| 2024-10-14 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
F | Common Stock | D | 8851 | $9.77 - $9.77 | $86,474 |
| 2024-10-14 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
M | Common Stock | A | 2813 | $0.00 - $0.00 | $0 |
| 2024-10-14 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
F | Common Stock | D | 1428 | $9.77 - $9.77 | $13,951 |
| 2024-10-14 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
M | Common Stock | A | 2813 | $0.00 - $0.00 | $0 |
| 2024-10-14 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
F | Common Stock | D | 1428 | $9.77 - $9.77 | $13,951 |
| 2024-07-15 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
M | Common Stock | A | 20835 | $0.00 - $0.00 | $0 |
| 2024-07-15 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
F | Common Stock | D | 8851 | $8.68 - $8.68 | $76,826 |
| 2024-07-15 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
M | Common Stock | A | 2813 | $0.00 - $0.00 | $0 |
| 2024-07-15 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
F | Common Stock | D | 1428 | $8.68 - $8.68 | $12,395 |
| 2024-07-15 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
M | Common Stock | A | 2813 | $0.00 - $0.00 | $0 |
| 2024-07-15 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
F | Common Stock | D | 1428 | $8.68 - $8.68 | $12,395 |
| 2024-06-03 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
M | Common Stock | A | 3906 | $0.00 - $0.00 | $0 |
| 2024-06-03 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
F | Common Stock | D | 1982 | $8.37 - $8.37 | $16,589 |
| 2024-06-03 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
M | Common Stock | A | 3516 | $0.00 - $0.00 | $0 |
| 2024-06-03 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
F | Common Stock | D | 1784 | $8.37 - $8.37 | $14,932 |
| 2024-06-03 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
M | Common Stock | A | 10417 | $0.00 - $0.00 | $0 |
| 2024-06-03 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
F | Common Stock | D | 4426 | $8.37 - $8.37 | $37,045 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |